CRISPR Therapeutics AG (CRSP) stock
CRSPNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$40.19+0.04 (+0.10%)
Close on Nov 18, 2026Market cap $3.89BP/E –Yield –
CRISPR Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
CRISPR Therapeutics's market cap was $4.42B on Nov 11, 2026, against $5.02B a year earlier. Over the last 5 years it ranged from $2.92B to $6.74B, with a median of $4.58B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $4.42B | -10.2% |
| 2025 | Dec 31, 2025 | $4.92B | +46.6% |
| 2024 | Dec 31, 2024 | $3.36B | -32.4% |
| 2023 | Dec 29, 2023 | $4.97B | +56.3% |
| 2022 | Dec 30, 2022 | $3.18B | -45.1% |
| 2021 | Dec 31, 2021 | $5.79B | -46.4% |
| 2020 | Dec 31, 2020 | $10.81B | +221.6% |
| 2019 | Dec 31, 2019 | $3.36B | +128.2% |
| 2018 | Dec 31, 2018 | $1.47B | +55.3% |
| 2017 | Dec 29, 2017 | $948.17M | +781.7% |
| 2016 | Dec 30, 2016 | $107.54M | – |
See a number that looks wrong?